The women's health initiative observational study: baseline characteristics of participants and reliability of baseline measures
Introduction
The Women's Health Initiative (WHI) Observational Study (OS) was established to explore the predictors and natural history of important causes of morbidity and mortality in postmenopausal women, and to serve as a secular control for the WHI Clinical Trial (CT). It enrolled 93,676 ethnically diverse women born in four different decades, from those who came of age in the depression-era, to the first members of the baby boom. Accordingly, this cohort reflects a wide range of socio-cultural influences on opportunities and health behaviors.
OS participants will contribute longitudinal data on health status, risk exposures and disease events. The follow-up interval will be slightly shorter than that in the clinical trial, approximately 7 years. All OS women had a physical examination at baseline and 3 years. Additional data are obtained with annual mailed questionnaires. These forms explore risk exposures, health behaviors, and the prevalence of less common diseases to provide a comprehensive view of both classical and novel risk factors, as well as secular trends in the predictors of healthy aging and disease events. Because of its size, the OS will permit exploration of factors associated with less common diseases.
This article describes the demographic, reproductive, dietary, and health characteristics of the OS women by ethnicity and age. In addition, we present information on the reliability of many of the baseline measures assessed in a subset of participants who were selected for the Measurement Precision Study (OS-MPS).
Section snippets
Methods
Study participants were enrolled at 40 centers throughout the United States between October 1, 1993 and December 31, 1998. Potential subjects were excluded if they did not plan to reside in the area for at least 3 years, had medical conditions predictive of survival less than 3 years, or had complicating conditions such as alcoholism, drug dependency or dementia. All participants provided informed consent using materials approved by institutional review boards at each center. Details of the
Results
93,726 women enrolled in the OS between September 1, 1994 and December 31, 1998. Of these, 31 provided insufficient baseline data to be included in these analyses, and 19 duplicate enrollments were found across multiple sites. After removing these, the remaining 93,676 women form the final analytic OS cohort, of which 78,013 (83.3%) were White, 7,639 (8.2%) Black, 3,623 (3.9%) Hispanic, 2,671 (2.9%) Asian/Pacific Islander, 422 (0.57%) American Indian, and 1308 (1.4%) of unknown race/ethnicity.
Discussion
The fraction of the US population comprised of ethnic minorities decreases with age and this is reflected in the composition of the WHI OS cohort. According to US Census data for women aged 50 to 59, 60 to 69, and 70 to 79 years, the fraction of Blacks declines from 11% to 10% to 8%, and the fraction of Hispanics from 7% to 6% to 4%, while the fraction of Whites increases from 78% to 81% to 85% (4). The trends in the OS are similar but the minority fractions are slightly lower in each decade.
Acknowledgements
The Writing Group wishes to acknowledge the contributions of Sandra A. Daugherty, M.D., M.P.H., WHI Clinical Center, University of Nevada, Reno, NV, who passed away as this manuscript was being prepared.
References (21)
- et al.
Measurement characteristics of the Women's Health Initiative food frequency questionnaire
Ann Epidemiol
(1999) - et al.
Depression and endogenous melatonin in postmenopausal women
J Affect Disord
(2002) - et al.
Repeatability of interview-derived socio-demographic and medical information
J Clin Epidemiol
(1988) Design of the Women's Health Initiative clinical trial and observational study
Control Clin Trials
(1998)- et al.
Principles of Exposure Measurement in Epidemiology
(1994) Population projections of the United States by age, sex, race and Hispanic origin: 1995 to 2050. US Bureau of the Census, Current Population Reports, P-25-1130
(1996)- et al.
Baseline characteristics of the PEPI participants
Control Clin Trials
(1995) - et al.
Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS)
JAMA
(1997) - et al.
Heart disease risk factors and hormone use in postmenopausal women
JAMA
(1979) - et al.
Postmenopausal estrogen use and heart disease risk factors in the 1980s. Rancho Bernardo, Calif, revisited
JAMA
(1989)